NCT01586793View on ClinicalTrials.gov

Repetitive Transcranial Magnetic Stimulation for Treating Resistant Bipolar Depression

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Bipolar Depression
Interventions
DEVICE

Magstim Rapid2 Stimulator

1 Hz in 1 train of 20-minute duration (1,200 pulses per session) at 120% of the rMT.

DEVICE

Magstim Rapid2 Stimulator

10 Hz in 75 trains of 4-seconds duration, with 26-seconds intertrain intervals (3,000 pulses per session) at 120% of the rMT.

Trial Locations (1)

H4H1R3

Neuromodulation Research Clinic, Douglas Mental Health University Institute, Verdun

All Listed Sponsors
lead

Douglas Mental Health University Institute

OTHER

NCT01586793 - Repetitive Transcranial Magnetic Stimulation for Treating Resistant Bipolar Depression | Biotech Hunter | Biotech Hunter